- Home
- GMED
GMED
Globus Medical Inc.
as 12-18-2024 10:37am EST
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | AUDUBON |
| Market Cap: | 11.6B | IPO Year: | 2012 |
| Target Price: | $90.69 | AVG Volume (30 days): | 822.2K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.67 | EPS Growth: | -54.17 |
| 52 Week Low/High: | $49.33 - $87.22 | Next Earning Date: | 11-05-2024 |
| Revenue: | $2,478,596,000 | Revenue Growth: | 102.10% |
| Revenue Growth (this year): | 62.39% | Revenue Growth (next year): | 6.71% |
Stock Insider Trading Activity of Globus Medical Inc. (GMED)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Huller Kelly | GMED | SVP, GC, Corporate Secretary | Dec 2 '24 | Sell | $87.00 | 2,500 | $217,501.50 | 0 | |
| Davidar David D | GMED | Director | Nov 21 '24 | Sell | $85.00 | 40,000 | $3,400,049.99 | 172,713 | |
| Lemaitre Dan | GMED | Director | Nov 21 '24 | Sell | $85.01 | 14,375 | $1,221,893.21 | 0 | |
| Scavilla Daniel T | GMED | President, CEO | Nov 21 '24 | Sell | $85.00 | 130,000 | $11,050,000.00 | 0 | |
| Huller Kelly | GMED | SVP, GC, Corporate Secretary | Nov 6 '24 | Sell | $81.01 | 5,000 | $405,050.00 | 0 | |
| Scavilla Daniel T | GMED | President, CEO | Nov 6 '24 | Sell | $80.02 | 60,000 | $4,801,200.00 | 0 | |
| Davidar David D | GMED | Director | Oct 16 '24 | Sell | $75.04 | 50,000 | $3,751,813.00 | 172,713 |
Latest Globus Medical Inc. News
GMED Breaking Stock News: Dive into GMED Ticker-Specific Updates for Smart Investing
MT Newswires
an hour ago
Truist Securities Adjusts Price Target on Globus Medical to $90 From $85, Keeps Hold Rating
MT Newswires
3 hours ago
RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating
Zacks
a day ago
Reasons to Retain STE Stock in Your Portfolio Now
Zacks
a day ago
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks
5 days ago
Baxter Stock May Gain Following Five New Injectable Product Launches
Zacks
5 days ago
Reasons to Retain Alcon Stock in Your Portfolio for Now
Zacks
6 days ago
Reasons to Retain PacBio Stock in Your Portfolio for Now
Zacks
6 days ago
MBOT Stock Gains Following FDA Submission of the LIBERTY System
Compare GMED vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GMED Globus Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.